×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Carl L. Gordon

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
KROSKeros Therapeutics, Inc.Carl L. GordonDirectorNov 21, 2025Disposition to Issuer$17.75214,5223,807,766759,155Dec 18, 2025, 04:27 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorApr 09, 2025Sale$1.593,571,4285,678,5710Apr 11, 2025, 07:37 PM
MBXMBX Biosciences, Inc.Carl L. GordonDirectorFeb 18, 2025Buy$10.84143,1701,551,9633,255,000Feb 19, 2025, 05:56 PM
MBXMBX Biosciences, Inc.Carl L. GordonDirectorFeb 14, 2025Buy$9.8747,502468,7933,205,930Feb 19, 2025, 05:56 PM
MBXMBX Biosciences, Inc.Carl L. GordonDirectorSep 16, 2024Conversion-403,787-403,787Sep 17, 2024, 08:05 PM
MBXMBX Biosciences, Inc.Carl L. GordonDirectorSep 16, 2024Buy$16.00250,0004,000,000653,787Sep 17, 2024, 08:05 PM
MBXMBX Biosciences, Inc.Carl L. GordonDirectorSep 16, 2024Conversion-2,658,428-2,658,428Sep 17, 2024, 08:05 PM
MBXMBX Biosciences, Inc.Carl L. GordonDirectorSep 16, 2024Buy$16.00500,0008,000,0003,158,428Sep 17, 2024, 08:05 PM
KROSKeros Therapeutics, Inc.Carl L. GordonDirectorAug 13, 2024Sale$44.01250,00011,002,500899,212Aug 15, 2024, 05:06 PM
TERNTerns Pharmaceuticals, Inc.Carl L. GordonDirectorJul 15, 2024Sale$10.0050,976509,7604,843,421Jul 17, 2024, 08:53 PM
TERNTerns Pharmaceuticals, Inc.Carl L. GordonDirectorJul 16, 2024Sale$10.005,18851,8804,839,412Jul 17, 2024, 08:53 PM
AVBPArriVent Biopharma, Inc.Carl L. GordonDirectorJan 30, 2024Conversion-2,582,884-1,291,442Jan 31, 2024, 04:11 PM
AVBPArriVent Biopharma, Inc.Carl L. GordonDirectorJan 30, 2024Buy$18.00444,4447,999,9921,513,664Jan 31, 2024, 04:11 PM
ACETAdicet Bio, Inc.Carl L. GordonDirectorJan 25, 2024Buy$2.403,125,0007,500,0007,526,359Jan 26, 2024, 07:13 PM
ACETAdicet Bio, Inc.Carl L. GordonDirectorJun 27, 2023Buy$2.09875,0001,828,7505,685,259Jun 29, 2023, 04:51 PM
TERNTerns Pharmaceuticals, Inc.Carl L. GordonDirectorDec 23, 2022Buy$7.25137,9311,000,0004,882,854Dec 28, 2022, 05:46 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorNov 08, 2022Buy$3.21402,0001,290,42015,219,994Nov 10, 2022, 04:38 PM
TERNTerns Pharmaceuticals, Inc.Carl L. GordonDirectorAug 16, 2022Buy$2.423,690,0008,929,8004,744,923Aug 18, 2022, 04:50 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorMay 13, 2022Buy$2.4930,72276,49814,817,994May 13, 2022, 05:48 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorMay 11, 2022Buy$1.7964,700115,81314,690,178May 13, 2022, 05:48 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorMay 12, 2022Buy$2.3597,094228,17114,787,272May 13, 2022, 05:48 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorMay 06, 2022Buy$1.6310,20016,62614,510,319May 10, 2022, 06:19 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorMay 09, 2022Buy$1.5690,712141,51114,601,031May 10, 2022, 06:19 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorMay 10, 2022Buy$1.6024,44739,11514,625,478May 10, 2022, 06:19 PM
ACETAdicet Bio, Inc.Carl L. GordonDirectorDec 10, 2021Award/Grant$14.00214,2852,999,990242,285Dec 14, 2021, 07:06 PM
CMPXCompass Therapeutics, Inc.Carl L. GordonDirectorNov 04, 2021Buy$3.505,357,14318,750,00114,500,119Nov 08, 2021, 09:12 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 29, 2021Sale$23.3175,5551,761,1872,240,440Mar 31, 2021, 05:11 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 30, 2021Sale$23.9327,869666,9052,212,571Mar 31, 2021, 05:11 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 25, 2021Sale$24.7051,5231,272,6182,343,811Mar 26, 2021, 05:46 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 26, 2021Sale$23.8827,816664,2462,315,995Mar 26, 2021, 05:46 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 24, 2021Sale$24.8032,959817,3832,395,334Mar 26, 2021, 05:46 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 19, 2021Sale$26.4721,275563,1492,439,958Mar 23, 2021, 05:26 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 22, 2021Sale$26.477,673203,1042,432,285Mar 23, 2021, 05:26 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 23, 2021Sale$24.323,99297,0852,428,293Mar 23, 2021, 05:26 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 16, 2021Sale$27.7241,3531,146,3052,486,082Mar 18, 2021, 09:04 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 17, 2021Sale$28.4318,790534,2002,467,292Mar 18, 2021, 09:04 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 18, 2021Sale$28.036,059169,8342,461,233Mar 18, 2021, 09:04 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 11, 2021Sale$33.0458,5511,934,5252,707,166Mar 15, 2021, 08:50 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 12, 2021Sale$30.2990,5212,741,8812,616,645Mar 15, 2021, 08:50 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorMar 15, 2021Sale$29.1489,2102,599,5792,527,435Mar 15, 2021, 08:50 PM
ACETAdicet Bio, Inc.Carl L. GordonDirectorFeb 12, 2021Award/Grant$13.00524,3496,816,5375,243,259Feb 18, 2021, 09:41 PM
TERNTerns Pharmaceuticals, Inc.Carl L. GordonDirectorFeb 09, 2021Conversion-3,316,204-1,989,723Feb 09, 2021, 03:10 PM
TERNTerns Pharmaceuticals, Inc.Carl L. GordonDirectorFeb 09, 2021Buy$17.00475,0008,075,0002,274,723Feb 09, 2021, 03:10 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorApr 24, 2020Buy$16.00281,2504,500,000281,250Apr 28, 2020, 05:07 PM
ORICOric Pharmaceuticals, Inc.Carl L. GordonDirectorApr 28, 2020Conversion-2,484,467-2,765,717Apr 28, 2020, 05:07 PM
KROSKeros Therapeutics, Inc.Carl L. GordonDirectorApr 13, 2020Conversion-893,534-744,612Apr 13, 2020, 05:12 PM
KROSKeros Therapeutics, Inc.Carl L. GordonDirectorApr 13, 2020Buy$16.00375,2006,003,2001,119,812Apr 13, 2020, 05:12 PM
ALECAlector, Inc.Carl L. GordonDirectorFeb 11, 2019Conversion-12,682,329-10,277,037Feb 11, 2019, 07:06 PM
ALECAlector, Inc.Carl L. GordonDirectorFeb 11, 2019Buy$19.00411,7007,822,30010,434,976Feb 11, 2019, 07:06 PM
ASNSArsanis, Inc.Carl L. GordonDirectorNov 20, 2017Buy$10.00500,0005,000,0001,868,966Nov 20, 2017, 05:31 PM
ASNSArsanis, Inc.Carl L. GordonDirectorNov 20, 2017Conversion-1,368,966-1,368,966Nov 20, 2017, 05:31 PM
SELBSELECTA BIOSCIENCES INCCarl L. GordonDirectorJun 27, 2016Conversion-1,177,995-1,280,604Jun 29, 2016, 04:49 PM
SELBSELECTA BIOSCIENCES INCCarl L. GordonDirectorJun 27, 2016Buy$14.00550,0007,700,0001,825,415Jun 29, 2016, 04:49 PM
NTLAIntellia Therapeutics, Inc.Carl L. GordonDirectorMay 11, 2016Conversion-2,412,180-2,412,180May 11, 2016, 06:36 PM
NTLAIntellia Therapeutics, Inc.Carl L. GordonDirectorMay 11, 2016Buy$18.00250,0004,500,0002,662,180May 11, 2016, 06:36 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorSep 04, 2012Sale$14.43233,7003,372,992594,300Sep 05, 2012, 05:38 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorJul 27, 2012Sale$14.61366,3005,350,691825,756Jul 30, 2012, 07:32 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorJun 19, 2012Sale$12.94617,1007,986,7011,188,600Jun 19, 2012, 07:37 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorApr 29, 2011Sale$16.01100,0001,601,0001,832,400May 03, 2011, 07:20 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMay 02, 2011Sale$16.3032,900536,2701,799,800May 03, 2011, 07:20 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorApr 20, 2011Sale$15.79792,40012,511,9962,674,300Apr 26, 2011, 08:16 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorApr 20, 2011Sale$15.797,600120,00425,700Apr 26, 2011, 08:16 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorApr 21, 2011Sale$16.67750,00012,500,0002,426,667Apr 25, 2011, 09:51 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorApr 18, 2011Sale$15.183,000,00045,549,8974,682,029Apr 20, 2011, 09:43 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorApr 20, 2011Sale$15.79800,00012,632,0002,674,300Apr 20, 2011, 09:43 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 28, 2011Sale$7.3593,100684,2856,438,500Mar 28, 2011, 09:45 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 24, 2011Sale$7.5023,000172,5006,587,100Mar 28, 2011, 09:45 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 25, 2011Sale$7.4756,900425,0436,530,700Mar 28, 2011, 09:45 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 21, 2011Sale$7.0577,000542,8506,609,900Mar 23, 2011, 06:31 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 11, 2011Sale$7.43100,000743,0006,810,000Mar 15, 2011, 09:34 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 14, 2011Sale$7.3375,000549,7506,735,700Mar 15, 2011, 09:34 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 15, 2011Sale$7.2450,000362,0006,686,200Mar 15, 2011, 09:34 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 03, 2011Sale$7.767,00054,3206,976,500Mar 07, 2011, 09:51 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 04, 2011Sale$7.6243,000327,6606,933,900Mar 07, 2011, 09:51 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 07, 2011Sale$7.6825,000192,0006,909,100Mar 07, 2011, 09:51 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 01, 2011Sale$7.5650,000378,0007,077,500Mar 02, 2011, 08:33 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorMar 02, 2011Sale$7.7295,000733,4006,983,400Mar 02, 2011, 08:33 PM
AMRNAMARIN CORP PLCUKCarl L. GordonDirectorFeb 28, 2011Sale$7.73100,000773,0007,127,000Mar 02, 2011, 08:33 PM
PCRXPacira Pharmaceuticals, Inc.Carl L. GordonDirectorFeb 08, 2011Conversion$4.352,200,2479,576,9002,293,227Feb 10, 2011, 06:47 PM
PCRXPacira Pharmaceuticals, Inc.Carl L. GordonDirectorFeb 08, 2011Buy$7.00535,7143,749,9982,828,941Feb 10, 2011, 06:47 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe